OP
WST icon

ORG Partners’s West Pharmaceutical WST Stock Holding History

ORG Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$8.53K Hold
31
– – ﹤0.01% 1057
2025
Q3 		$8.13K Buy
31
+7
+29% +$1.7K ﹤0.01% 1017
2025
Q2 		$5.34K Sell
24
-30
-56% -$6.41K ﹤0.01% 1043
2025
Q1 		$65.4K Sell
54
-211
-80% -$58.2K 0.02% 445
2024
Q4 		$86.8K Buy
265
+4
+2% +$1.26K 0.01% 453
2024
Q3 		$78.3K Sell
261
-308
-54% -$94.3K 0.01% 434
2024
Q2 		$185K Buy
569
+431
+312% +$152K 0.02% 447
2024
Q1 		$54.6K Buy
138
+123
+820% +$45.5K 0.1% 127
2023
Q4 		$5.33K Sell
15
-1,421
-99% -$503K ﹤0.01% 839
2023
Q3 		$539K Sell
1,436
-201
-12% -$77.7K 0.16% 148
2023
Q2 		$624K Buy
+1,637
New +$585K 0.1% 182

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ORG Partners's WST Position: Q4 2025 in Review

ORG Partners held its West Pharmaceutical (WST) position steady in Q4 2025 at 31 shares worth $8.53K. The position accounts for ﹤0.01% of the portfolio, ranked #1057.

ORG Partners first reported a position in WST in Q2 2023 and has held it in 11 quarters since. The position peaked at $624K in Q2 2023. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • ORG Partners held 31 shares of West Pharmaceutical worth $8.53K as of Q4 2025.
  • ORG Partners left its West Pharmaceutical share count unchanged in Q4 2025.
  • West Pharmaceutical made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1057 holding.
  • ORG Partners first reported a position in West Pharmaceutical in Q2 2023 and has held it in 11 quarters since.
  • ORG Partners's West Pharmaceutical position peaked at $624K in Q2 2023.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.